1 not yet recruiting, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Unknown 1 |
Follow Tumor Infiltrating Lymphocyte Therapy: new trials by email Literature Review of Tumor Infiltrating Lymphocyte Therapy trials Research Report on Tumor Infiltrating Lymphocyte Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors Aldesleukin, Biospecimen Collection, Chest Radiography - Locally Advanced Gastrointestinal Stromal Tumor, Metastatic Gastrointestinal Stromal Tumor | Phase 2 | Not yet recruiting | Joal Beane | 59 | 2027-02-15 | 2026-10-13 |
| Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas tumor infiltrating lymphocyte therapy, gemcitabine hydrochloride - Pancreatic Cancer | Phase 2 | Unknown | Meyer Pharmaceuticals | 150 | 1998-12-01 | 2013-12-19 |
Gastrointestinal Stromal Tumors (1) · Pancreatic Neoplasms (1)
Joal Beane (1) · Meyer Pharmaceuticals (1)
United States (2)
Joal Beane, MD (1) · Michael F. O'Neill (1)